Comparison Chart Avalo Therapeutics, Inc.

Stocks

AVTX

US05338F3064

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-10 EDT			5-day change	1st Jan Change
17.18 ^USD	-5.66%		-11.17%	-5.40%

08-19	Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing	MT
08-06	Avalo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	AVALO THERAPEUTICS, INC.	Bio Therapeutic Drugs	-5.66%	-11.17%	-5.40%	+47.98%	-99.78%	977M